Literature DB >> 24678492

Aggressive angiomyxoma of the vulva: A case report.

Kyoung-A Lee1, Jung-Won Seo1, Na-Ra Yoon2, Jeong-Won Lee1, Byoung-Gie Kim1, Duk-Soo Bae1.   

Abstract

Aggressive angiomyxoma (AA) is an unusual mesenchymal tumor. AA occurs most commonly in women of reproductive age and is located in the perineal or pelvic region. This is a distinct soft tissue tumor that has a prominent myxoid matrix and numerous thin-walled blood vessels and may have an aggressive local recurrence. The tumors have the characteristics of large size (usually greater than 10 cm) and slow growth, and are not painful. The standard treatment for AA is total excision and close follow-up. We announce a case of a 35 year-old female presenting with a pedunculated AA on the right labium majora that has not relapsed for seven years.

Entities:  

Keywords:  Mesenchymal tumor; Myxoma; Vulva

Year:  2014        PMID: 24678492      PMCID: PMC3965702          DOI: 10.5468/ogs.2014.57.2.164

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN: 2287-8572


  9 in total

1.  Aggressive angiomyxoma: multimodality treatments can avoid mutilating surgery.

Authors:  I J M Han-Geurts; A N van Geel; L van Doorn; A M M Eggermont; C Verhoef
Journal:  Eur J Surg Oncol       Date:  2006-07-25       Impact factor: 4.424

2.  Aggressive angiomyxoma: findings on CT and MR imaging.

Authors:  E K Outwater; B E Marchetto; B J Wagner; E S Siegelman
Journal:  AJR Am J Roentgenol       Date:  1999-02       Impact factor: 3.959

3.  Aggressive angiomyxoma of the vulva.

Authors:  A Amin; S El Badawy; A Bull
Journal:  J Obstet Gynaecol       Date:  2013-04       Impact factor: 1.246

4.  Vulvar angiomyxoma, aggressive angiomyxoma, and angiomyofibroblastoma: an immunohistochemical and ultrastructural study.

Authors:  Francesc Alameda; Assumpció Munné; Teresa Baró; Mar Iglesias; Enric Condom; Josep Lloreta-Trull; Sergi Serrano
Journal:  Ultrastruct Pathol       Date:  2006 May-Jun       Impact factor: 1.094

5.  Aggressive angiomyxoma of the vulva: Dramatic response to gonadotropin-releasing hormone agonist therapy.

Authors:  W G McCluggage; T Jamieson; S P Dobbs; A Grey
Journal:  Gynecol Oncol       Date:  2005-10-21       Impact factor: 5.482

Review 6.  Myxoid tumours of soft tissue.

Authors:  J F Graadt van Roggen; P C Hogendoorn; C D Fletcher
Journal:  Histopathology       Date:  1999-10       Impact factor: 5.087

7.  Aggressive angiomyxoma of the female pelvis and perineum: a case series.

Authors:  P M Magtibay; Z Salmon; G L Keeney; K C Podratz
Journal:  Int J Gynecol Cancer       Date:  2006 Jan-Feb       Impact factor: 3.437

Review 8.  Aggressive angiomyxoma: a case series and literature review.

Authors:  K Haldar; I E Martinek; S Kehoe
Journal:  Eur J Surg Oncol       Date:  2009-12-01       Impact factor: 4.424

9.  Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm.

Authors:  T A Steeper; J Rosai
Journal:  Am J Surg Pathol       Date:  1983-07       Impact factor: 6.394

  9 in total
  4 in total

1.  Novel HMGA2-YAP1 fusion gene in aggressive angiomyxoma.

Authors:  Mee-Young Lee; Brandon da Silva; Daniel C Ramirez; Robert G Maki
Journal:  BMJ Case Rep       Date:  2019-05-28

2.  Aggressive angiomyxoma of the vulva: a bizarre perineal lesion.

Authors:  Adamantia Zizi-Sermpetzoglou; Despoina Myoteri; Kalliroi Koulia; Vassilios Kontostolis; Hippokratis Moschouris; Dionysios Dellaportas
Journal:  Case Rep Oncol Med       Date:  2015-04-22

3.  Aggressive angiomyxoma: case report and review of the literature.

Authors:  John C Benson; Scott Gilles; Tina Sanghvi; James Boyum; Eric Niendorf
Journal:  Radiol Case Rep       Date:  2016-10-28

Review 4.  Incidental para-ureteral aggressive angiomyxoma: a rare case report and literature review.

Authors:  Ming Liu; Ting-Shuai Zhai; Xiao-Feng Zhao; Li-Jin Feng; Xin-Sheng Lyu; Lan-Ting Hu; Zheng-Xin Wang; Wei-Guo Ma; Jian Zhang; Xiao Chen; Bin-Jie Su; Xu-Dong Yao; Jing-Yi Lu; Lin Ye
Journal:  BMC Urol       Date:  2020-11-10       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.